Real Life Study of Lenvatinib Therapy for Hepatocellular Carcinoma: RELEVANT Study

INTRODUCTION: In the REFLECT trial, lenvatinib was found to be noninferior compared to sorafenib in terms of overall survival. Here, we analyze the effects of lenvatinib in the real-life experience of several centers across the world and identify clinical factors that could be significantly associat...

Descripción completa

Detalles Bibliográficos
Autores principales: Casadei-Gardini, Andrea, Rimini, Margherita, Kudo, Masatoshi, Shimose, Shigeo, Tada, Toshifumi, Suda, Goki, Goh, Myung Ji, Jefremow, Andre, Scartozzi, Mario, Cabibbo, Giuseppe, Campani, Claudia, Tamburini, Emiliano, Tovoli, Francesco, Ueshima, Kazuomi, Aoki, Tomoko, Iwamoto, Hideki, Torimura, Takuji, Kumada, Takashi, Hiraoka, Atsushi, Atsukawa, Masanori, Itobayashi, Ei, Toyoda, Hidenori, Sakamoto, Naoya, Sho, Takuya, Kang, Wonseok, Siebler, Jürgen, Neurath, Markus Friedrich, Burgio, Valentina, Cascinu, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801178/
https://www.ncbi.nlm.nih.gov/pubmed/36589723
http://dx.doi.org/10.1159/000525145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801178/
https://www.ncbi.nlm.nih.gov/pubmed/36589723
http://dx.doi.org/10.1159/000525145

Ejemplares similares